expensive < experience < experienced

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]

Ident.	Authors (with country if any)	Title
000016 (2009)	Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]	The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000031 (2005)	Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]	Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000211 (2006)	Lyndell Lim [États-Unis] ; Eric B. Suhler [États-Unis] ; Justine R. Smith [États-Unis]	Biologic therapies for inflammatory eye disease
000224 (2013)	Lydia Bresolin [Australie, Niger]	A mother describes her child's experience with juvenile arthritis
000238 (2012)	H. G. Nü Lein [Allemagne]	Wie früh würden wir Biologika wirklich einsetzen?
000268 (2012)	Vishnu V. Reddy Munagala [Inde] ; Ramnath Misra [Inde] ; Vikas Agarwal [Inde] ; Able Lawrence [Inde] ; Amita Aggarwal [Inde]	Adult onset Still's disease: experience from a tertiary care rheumatology unit
000279 (2010)	Arnd Heiligenhaus [Allemagne] ; Stephan Thurau [Allemagne] ; Maren Hennig [Allemagne] ; Rafael S. Grajewski [Allemagne] ; Gerhild Wildner [Allemagne]	Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease
000350 (2013)	G. Horneff ; N. Onken ; A. Hospach [Allemagne] ; G. Ganser ; H. I. Huppertz [Allemagne]	SAT0462 Experience with Tocilizumab in 29 Patients with Systemic Onset Juvenile Idiopathic Arthritis
000354 (2013)	S. C. Horton [Royaume-Uni] ; S. Das [Royaume-Uni] ; D. Bryer [Royaume-Uni] ; P. Emery [Royaume-Uni] ; M. H. Buch [Royaume-Uni]	AB0573 Tocilizumab use in a diverse patient population: Single-centre tertiary experience
000375 (2013)	G. Horneff ; S. Nimmrich [Allemagne]	SAT0463 Incidence of Herpes Zoster Infections in Juvenile Idiopathic Arthritis Patients – Experience of the Biker Registry
000387 (2013)	R. Denisova ; E. Alekseeva [Russie] ; S. Valieva ; T. Bzarova ; K. Isayeva ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] ; A. Fetisova	SAT0445 Survival of Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Russian Experience
000397 (2013)	S. Rodionovskaya [Russie] ; I. Nikishina [Russie]	AB0700 Successful experience with tocilizumab in two patients with macrophage activation syndrome associated with juvenile idiopathic arthritis
000406 (2013)	E. Alekseeva [Russie] ; R. Denisova ; S. Valieva ; T. Bzarova ; K. Isayeva ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] ; A. Fetisova	SAT0459 Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Russian Experience
000442 (2013)	Y. Muraviev ; M. Podryadnova [Russie] ; E. Nasonov [Russie]	AB0588 Experience of tocilizumab using for resistant adult-onset still’s disease
000501 (2013)	S. Das [Royaume-Uni] ; S. Horton [Royaume-Uni] ; E. Vital ; D. Bryer [Royaume-Uni] ; P. Emery [Royaume-Uni] ; M. Buch [Royaume-Uni]	THU0089 Response to abatacept and tocilizumab in patients who had failed rituximab– initial single centre experience
000523 (2013)	E. Quesada-Masachs [Espagne] ; C. Díaz [Espagne] ; G. Avila [Espagne] ; I. Acosta [Espagne] ; X. Sans [Espagne] ; C. Alegre [Espagne] ; J. J. Agustín [Espagne] ; S. Marsal [Espagne]	AB0530 Efficacy and safety of tocilizumab in patients with rheumatoid arthritis in clinical practice: Two years’ experience
000585 (2013)	A. Alexeeva [Russie] ; Y. Mouraviev [Russie] ; E. Nasonov [Russie]	AB0341 Experience of tocilizumab usage in chronic renal insufficiency stipulated by aa-amyloidosis due to rheumatoid arthritis complication
000597 (2013)	M. Dubko [Russie] ; O. Kalashnikova [Russie] ; M. Kostik [Russie] ; L. Snegireva [Russie]	AB0554 Abatacept (ORENCIA): Experience of practical application
000619 (2013)	M. Can [Turquie] ; F. Alibaz-Öner [Turquie] ; S. Öner [Turquie] ; P. Atagunduz [Turquie] ; N. Inanc [Turquie] ; H. Direskeneli [Turquie]	AB0558 Accelerated infusion rates of RITUXIMAB is well-tolerated and safe in rheumatology practice: A single center experience
000670 (2013)	A. Liakos [Royaume-Uni] ; M. Batley [Royaume-Uni] ; T. Hammond [Royaume-Uni] ; A. Saha [Royaume-Uni] ; P. Shrestha [Royaume-Uni] ; A. Keough [Royaume-Uni]	AB0593 Subcutaneous methotrexate is more efficacious and better tolerated than oral methotrexate: The experience of a large group of patients in the rheumatology department of a district general hospital
000718 (2013)	E. Della Torre [Italie] ; S. Franchini [Italie] ; E. Baldissera [Italie] ; G. Cavalli ; E. P. Bozzolo [Italie] ; M. G. Sabbadini [Italie]	THU0386 Efficacy of long-term treatment with biologic agents in refractory adult onset still’s disease: A single centre experience on 16 patients

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "experience" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "experience" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    experience
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021